Results 161 to 170 of about 4,889,938 (291)

Binding of KRH‐594, an antagonist of the angiotensin II type 1 receptor, to cloned human and rat angiotensin II receptors

, 2002
Yoichi Inada, Tokio Nakane, Shigetoshi Chiba   +2 more
openalex   +1 more source

Angiotensin II and Thirst: Therapeutic Considerations [PDF]

, 2001
Domenic A. Sica
openalex   +1 more source

Leptin Mediates High-Fat Diet Sensitization of Angiotensin II–Elicited Hypertension by Upregulating the Brain Renin–Angiotensin System and Inflammation

HYPERTENSION, 2016
B. Xue, Yang Yu, Zhongmin Zhang, F. Guo, T. Beltz, R. Thunhorst, R. Felder, A. Johnson   +7 more
semanticscholar   +1 more source

Growth differentiation factor‐15 and N‐terminal pro‐BNP in acute heart failure with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 888-899, April 2025.
Abstract Aims Heart failure with preserved ejection fraction (HFpEF) continues to be an increasingly common health problem associated with a high mortality rate. Elevated levels of Growth differentiation factor‐15 (GDF15) and N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) are reportedly associated with poor clinical outcomes in a broad range of ...
Yoichiro Otaki, Tetsu Watanabe, Mari Shimizu, Shingo Tachibana, Junya Sato, Yuta Kobayashi, Harutoshi Tamura, Shigehiko Kato, Satoshi Nishiyama, Hiroki Takahashi, Takanori Arimoto, Masafumi Watanabe   +11 more
wiley   +1 more source

Vasoactive Agents in Burn Patients: Perspectives on Angiotensin-II. [PDF]

J Burn Care Res
Mueller SW, Tran NM, Betthauser KD, Buckley MS, Shupp J, Wiktor AJ, Hill DM.   +6 more
europepmc   +1 more source

Multivariate linear regression to predict association of non‐invasive arterial stiffness with cardiovascular events

ESC Heart Failure, Volume 12, Issue 2, Page 1141-1150, April 2025.
Abstract Background Arterial stiffness is a crucial factor in determining an increase in systolic blood pressure and pulse pressure and can also predict the development of cardiovascular disease (CVD). The purpose of this study was to examine the relationship between arterial stiffness and future CVD.
Susan Darroudi, Mostafa Eslamiyeh, Amin Mansoori, Eisa Nazar, Maryam Alinezhad‐Namaghi, Reza Rezvani, Majid Ghayour‐Mobarhan, Habibollah Esmaily, Mohsen Moohebati, Gordon A. Ferns, Mark Ghamsary   +10 more
wiley   +1 more source

Effects of an angiotensin II antagonist on organ perfusion during the post-resuscitation phase in pigs [PDF]

, 1998
Hans-Ulrich Strohmenger, Karl H. Lindner, Wolfgang Wienen, Peter Radermacher   +3 more
openalex   +1 more source

The in‐hospital administration of sacubitril/valsartan in acute myocardial infarction: A meta‐analysis

ESC Heart Failure, Volume 12, Issue 2, Page 998-1012, April 2025.
In patients with Acute Myocardial Infarction related heart failure, the in‐hospital administration of ARNIs was associated with a reduced risk of MACEs and re‐hospitalizations for heart failure, as well as cardiac remodeling, compared to standard therapy.
Gianluca Di Pietro, Riccardo Improta, Paolo Severino, Andrea D'Amato, Lucia Ilaria Birtolo, Ovidio De Filippo, Antonio Lattanzio, Raffaele De Cristofaro, Giacchino Galardo, Fabrizio D'Ascenzo, Roberto Badagliacca, Gennaro Sardella, Maurizio Volterrani, Francesco Fedele, Carmine Dario Vizza, Massimo Mancone   +15 more
wiley   +1 more source

HSPD1 regulates angiotensin II‑induced atrial fibrillation via the PPAR signaling pathway. [PDF]

Mol Med Rep
Zhou Y, Zhang L, Zhou S, Zhang W, Gong Q, Xu N, Wang J, Zhang Z, Chen N.   +8 more
europepmc   +1 more source

Corrigendum to “CO-releasing molecules CORM2 attenuates angiotensin II-induced human aortic smooth muscle cell migration through inhibition of ROS/IL-6 generation and matrix metalloproteinases-9 expression” [Redox Biol. 12 (2017) 377–388]

, 2018
Ming-Horng Tsai, Chiang‐Wen Lee, Lee-Fen Hsu, Shu-Yu Li, Yao‐Chang Chiang, Ming‐Hsueh Lee, Chun‐Han Chen, Hwey-Fang Liang, Jia-Mei How, Pey‐Jium Chang, Ching-Mei Wu, I.-Ta Lee   +11 more
openalex   +1 more source